Faculty Advisor

Medich, David Christopher

Abstract

Any radioactive source used in brachytherapy must be fully characterized according the TG-43 protocol in order to be approved by the FDA for clinical use. One of the parameters that must be characterized per the protocol is the anisotropy function. Iridium-192 is the most common and standard source to use in brachytherapy. The anisotropy of a specific iridium-192 brachytherapy seed has been analyzed using Gafchromic film dosimetry as part of the characterization needed for FDA approval.

Publisher

Worcester Polytechnic Institute

Date Accepted

April 2018

Major

Physics

Project Type

Major Qualifying Project

Accessibility

Unrestricted

Advisor Department

Physics

Share

COinS